Market Place
Sourcing Support
All News #Library
Biotech
Diakonos Oncology Presents Phase 1 Pancreatic Cancer Study
01 May 2026 //
FIRSTWORD PHARMA
Diakonos Oncology to Present DOC1021 Data in Pancreatic Cancer
18 Mar 2026 //
PR NEWSWIRE
Diakonos Announces First DSMB Safety Review of DOC1021
17 Feb 2026 //
PR NEWSWIRE
Diakonos Oncology to Present, Join Panel at Biotech 2026
15 Dec 2025 //
PR NEWSWIRE
CPRIT Funds Diakonos for DOC1021 Melanoma Therapy
10 Dec 2025 //
PR NEWSWIRE
Diakonos Oncology Unveils Positive Phase 1 Data For DOC1021
07 Nov 2025 //
PR NEWSWIRE
Diakonos Oncology To Present DOC1021 Immunotherapy Data At SITC
27 Oct 2025 //
PR NEWSWIRE
Diakonos Oncology doses first patient in DOC1021 trial
22 Jul 2025 //
PR NEWSWIRE
Diakonos Oncology Secures $20M to Advance Glioblastoma Program
30 May 2025 //
PR NEWSWIRE
Diakonos Oncology to Present Ph I Results of Dubodencel at ASCO
28 May 2025 //
PR NEWSWIRE
Diakonos Oncology presents Phase I analysis of DOC1021
09 Apr 2025 //
PR NEWSWIRE
Diakonos Oncology Appoints Laura as Chief Medical Officer
18 Nov 2024 //
BUSINESSWIRE
Neurosurgeon Joseph Georges Receives CNS 2024 Research Award
15 Oct 2024 //
BUSINESSWIRE
Diakonos` Vaccine Shows 93% Survival For Glioblastoma Patients
01 Oct 2024 //
BUSINESSWIRE
Diakonos Appoints Biotech Veteran Anthony Baldor as Chief Financial Officer
26 Feb 2024 //
BUSINESSWIRE
Diakonos Oncology Completes Phase 1 Glioblastoma Trial Recruitment
02 Jan 2024 //
BUSINESSWIRE
Diakonos Awarded FDA Fast Track Designation for Dendritic Cell Vaccine
17 Oct 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.